基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 抑制剂 神经信号通路(Neuronal Signaling) COX 抑制剂 扎托布洛芬 扎托布洛芬
  • aladdin 阿拉丁 Z407872 扎托布洛芬 74711-43-6 10mM in DMSO

aladdin 阿拉丁 Z407872 扎托布洛芬 74711-43-6 10mM in DMSO

Zaltoprofen
74711-43-6
581.90 1ml 起订
上海 更新日期:2024-04-22

上海阿拉丁生化科技股份有限公司

VIP1年
联系人:阿拉丁客服
手机:+86-18521732826 拨打
邮箱:market@aladdin-e.com

产品详情:

中文名称:
扎托布洛芬
英文名称:
Zaltoprofen
CAS号:
74711-43-6
品牌:
阿拉丁
产地:
上海
保存条件:
-80℃储存
纯度规格:
10mM in DMSO
产品类别:
药靶配体 药靶配体
分子式:
C17H14O3S
分子量:
298.36
运输条件:
超低温冰袋运输
产品规格:
1ml
货号:
Z407872
是否进口:

中文名:扎托布洛芬

英文名:Zaltoprofen

英文别名:10,​11-​dihydro-​α-​methyl-​10-​oxo-dibenzo[b,​f]​thiepin-​2-​acetic acid

纯度:10mM in DMSO

货号:Z407872

包装:1ml

Cas号:74711-43-6

存储温度:-80℃储存

产品介绍:

Information

Zaltoprofen is an inhibitor ofCOX-1andCOX-2for treatment of arthritis.
In vitro

Zaltoprofen binds to specific sites on the protein of the bradykinin B2 receptor, hence we have examined the effect of zaltoprofen on bradykinin-induced responses of adult DRG neurons to investigate possible interaction sites. Zaltoprofen most potently inhibits bradykinin-enhancement of capsaicin-induced Ca2+ uptake into DRG neurons. Zaltoprofen also significantly inhibits bradykinin-induced 12-lipoxygenase (12-LOX) activity and the slow bradykinin-induced onset of substance P release from DRG neurons. Zaltoprofen produces an analgesic action on bradykinin-induced nociceptive responses by blocking the B(2) receptor-mediated pathway in the primary sensory neurons. Zaltoprofen completely inhibits the bradykinin-induced increase of [Ca(2+)](i), which is inhibited by B(2) antagonist D-Arg-[Hyp(3), Thi(5,8), D-Phe(7)]-bradykinin, but not by B(1) antagonist. Zaltoprofen at 1nmol shows strong analgesic action on BK (i.pl.)-induced nociceptive flexor responses, whereas loxoprofen or its active metabolite loxoprofen-SRS does not. Zaltoprofen also inhibits the nociception induced by [Tyr8]-BK, a specific agonist of B2-type BK receptor, but does not affect the nociception by [Lys-des-Arg9]-BK, a specific agonist of B1-type BK receptor. Zaltoprofen is a non-steroidal anti-inflammatory drug (NSAID) causes potent inhibition of cyclooxygenase-2 with fewer side effects on the gastrointestinal tract.

In vivo

Zaltoprofen improves the loss in body weight in both Con A-treated mice and carbon tetrachloride-treated rats. Zaltoprofen (10 mg/kg) administrated at 8 h after Con A treatment is found to inhibit the Con A-induced reduction in body weight. Zaltoprofen (10 mg/kg) combined with Con A results in four times greater food intake than that in mice treated with only Con A.
Cell Data

cell lines:

Concentrations:

Incubation Time:

Powder Purity:≥99%

查看阿拉丁官网此产品相关对应页面:https://www.aladdin-e.com/zh_cn/Z407872.html


10,?11-?dihydro-?α-?methyl-?10-?oxo-dibenzo[b,?f]?thiepin-?2-?acetic acid

公司简介

上海阿拉丁生化科技股份有限公司是A股上市公司((股票代码:688179),专注于科研试剂的研发、生产和销售,已陆续建立多个工厂和研发中心。作为领军企业,阿拉丁始终坚持质量第一,连续13年被评为“最受欢迎试剂品牌”。 阿拉丁目前常备库存试剂产品品种超过7万种,SKU总数超过46万,产品线涵盖了化学试剂、生化试剂、药靶配体、蛋白质和抗体等多个领域,是国内少数化学试剂到生物试剂全面发展的国产试剂品牌,产品同步发布在我们国内外电商平台。

成立日期 (16年)
注册资本 14130.676万人民币
员工人数 500人以上
年营业额 ¥ 1亿以上
经营模式 工厂,试剂
主营行业 生物化工,化学试剂

扎托布洛芬相关厂家报价 更多

内容声明
拨打电话 立即询价